Exposure-response Analyses for Optimal Therapeutic Dose Selection of ABBV-383 in Patients with Relapsed/refractory Multiple Myeloma (RRMM).
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined